Actualités

Q2 earnings and buybacks put Cigna Group in focus Cigna Group (CI) is back on investors’ radar after reporting its second quarter 2026 results, alongside an update on a long running share repurchase program dating back to 2018. See our latest analysis for Cigna Group. Cigna Group’s latest earnings and long running buyback program have come alongside mixed share price momentum. The stock is up 2.63% on the day and has a modest 1.21% share price return year to date, while the 5 year total...

A few sectors have dominated the market this year, and healthcare isn’t one of them. Many stocks in the sector look ready to gain.

CVS Health earnings surged past tepid forecasts after reporting its health benefit costs fell as a share of premiums. The pharmacy chain hiked its full-year outlook by a bit less than the Q2 beat. Analysts say that management's prudence in trying to grow its health benefits business let the company avoid the worst fallout from surprisingly strong medical care utilization.

The company published the arithmetic of its own margin repair, and the first hard proof landed a quarter before the shares started compounding.

Cigna delivers an earnings and revenue beat as Cigna Healthcare fuels growth, while the company raises its 2026 EPS outlook despite higher pharmacy costs.

Investing.com -- The Cigna Group (NYSE:CI) reported second-quarter earnings and revenue that exceeded analyst expectations, while raising its full-year outlook, though shares fell 1% premarket following the announcement.

Most S&P 500 investors assume they own the market, but one overlooked mechanism quietly determines how much cash actually flows back to shareholders, and ignoring it this year has carried a measurable price.

Cigna Group (CI) continues to draw investor attention after recent share moves, with the stock last closing at US$281.45. The company’s mixed return profile over various periods is prompting closer scrutiny of its valuation and fundamentals. See our latest analysis for Cigna Group. Recent trading shows some cooling in momentum for Cigna Group, with the 1 day share price return slipping 0.83% and the 7 day return down 4.09%. The 5 year total shareholder return of 32.51% points to a steadier...

Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.

UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.

While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.

Humana has rallied the Nasdaq Composite over the past year, and analysts remain moderately bullish about the stock’s outlook.

After a brutal stretch, the insurance behemoth came roaring back. But does the underlying data fully support the sustainability of this momentum.

Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside. Humana (NYSE:HUM) stock is leading the move, up 6% to $348, with UnitedHealth Group (NYSE:UNH) stock up 5% ... Humana Jumps 6%, UnitedHealth Climbs 5%, Cigna Rises 4% as Analysts Cheer Softer Medical Cost Trends

Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy benefit manager CVS Health.

The S&P 500 Index ($SPX ) (SPY ) today is up +0.81%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.74%. June E-mini S&P futures (ESM26 ) are up +0.77%, and June E-mini Nasdaq futures...

The S&P 500 Index ($SPX ) (SPY ) today is up +0.72%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.42%. June E-mini S&P futures (ESM26 ) are up +0.62%, and June E-mini Nasdaq futures...

With a 5-year dividend growth rate of 42.40%, The Cigna Group (NYSE:CI) is included among the 10 Best Dividend Growth Stocks to Buy and Hold for 3 Years. On May 22, UBS raised its price recommendation on The Cigna Group (NYSE:CI) to $400 from $375. It reiterated a Buy rating on the shares. The analyst said […]

Shares of Humana (NYSE:HUM) are trading near $303 at midday Monday, slightly lower on the session after a flat open. The one-month picture, however, tells a very different story. Humana stock is up 48% over the past month, dwarfing peers in the managed care complex. That run has put Humana well ahead of UnitedHealth Group ... Humana Just Ripped 48% in a Month. Is It Outperforming Other Healthcare Stocks Like UnitedHealth and Cigna?

With a 5-year average dividend growth rate of 42.4%, The Cigna Group (NYSE:CI) is included among the 14 Best Dividend Stocks to Buy for Steady Growth. On May 5, Bernstein analyst Lance Wilkes raised the firm’s price recommendation on The Cigna Group (NYSE:CI) to $371 from $358. It reiterated an Outperform rating following the company’s quarterly […]

CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.

CI beats Q1 EPS estimates as Evernorth revenues jump 9% despite rising pharmacy costs; 2026 EPS outlook lifted to at least $30.35.

Is CI a good stock to buy? We came across a bullish thesis on The Cigna Group on Quality At A Fair Price’s Substack. In this article, we will summarize the bulls’ thesis on CI. The Cigna Group’s share was trading at $279.92 as of April 20th. CI’s trailing and forward P/E were 12.62 and 9.23, respectively according to Yahoo Finance. […]